Recent events
Recent events tied to this brand in public sources.
Back to profile81 entries · Page 3 of 5
2021
FDA extends Pfizer-BioNTech vaccine authorization to ages 12–15
The FDA extended the emergency use authorization for Pfizer’s COVID-19 vaccine to cover children ages 12–15, allowing this age group to receive the vaccine.
2021
Pfizer reported first-quarter 2021 financial results
Pfizer reported first-quarter 2021 revenue of $14.582 billion, up 45% year over year, and net income of $4.877 billion, also up 45%.
2021
Pfizer announces acquisition of Amplyx Pharmaceuticals
Pfizer announced that it had acquired Amplyx Pharmaceuticals, a San Diego biotech developing treatments for microbes. Pfizer said it would continue testing Amplyx's experimental antifungal drug fosmanogepix and other earlier-stage therapies; the source does not establish that the acquisition had been completed.
2021
Pfizer acquires Amplyx Pharmaceuticals
Pfizer announced that it had acquired Amplyx Pharmaceuticals, which was evaluating its lead antifungal compound in Phase 2 trials. The article did not disclose financial terms.
2021
Pfizer offers its Covid-19 vaccine to India’s government at a not-for-profit price
Pfizer said it would offer its Covid-19 vaccine at a not-for-profit price for the Indian government’s immunization program. The company did not provide specific pricing details and said it was still in discussions with the government.
2021
Pfizer offers COVID-19 vaccine in India at a not-for-profit price
Pfizer offered to supply the Pfizer-BioNTech vaccine in India at a not-for-profit price; the source does not state the specific price offered.
2021
Pfizer and DoctorOnCall announce a collaboration
Pfizer announced a collaboration with DoctorOnCall to launch a digital therapeutics platform for smoking cessation, vaccination, and heart health in Malaysia.
2021
Celcuity and Pfizer enter a gedatolisib licensing agreement
Celcuity entered a worldwide licensing agreement with Pfizer for exclusive rights to develop and commercialize gedatolisib, which was in clinical development for advanced or metastatic breast cancer.
2021
Iktos announces collaboration with Pfizer on AI drug design
Iktos announced a collaboration with Pfizer to apply Iktos's artificial intelligence technology for de novo design to selected Pfizer small-molecule discovery programs.
2021
Pfizer announces expanded COVID-19 vaccine production capacity
Pfizer CEO Albert Bourla said the company would use additional manufacturing capacity and work with new suppliers to increase production of its COVID-19 vaccine. The announced plans include additional capacity at its Kalamazoo, Groton and McPherson sites.
2021
Imcyse concluded a €21.3 million Series B extension
Imcyse announced that it had concluded a Series B extension financing round, raising EUR 21.3 million. Pfizer participated as a new investor and took an equity stake in Imcyse.
2021
Pfizer and Imcyse agree to develop a rheumatoid arthritis program
Pfizer and Imcyse entered into a collaboration and licensing agreement for a rheumatoid arthritis program based on Imcyse's Imotope technology. Pfizer will lead clinical development.
2021
BioNTech and Pfizer announce increased EU vaccine deliveries
BioNTech and Pfizer announced that they would increase coronavirus vaccine deliveries to the European Union, pledging up to 75 million additional doses in the spring. They said increased production capabilities would allow them to accelerate supplies.
2021
Pfizer and AstraZeneca reduce vaccine deliveries to Italy
Italy's health deputy minister said Pfizer and AstraZeneca reduced vaccine supplies, delaying the vaccination schedule for people aged 80 and over by four weeks and for other age groups by six to eight weeks.
2021
Pfizer unveils new logo and visual identity
Pfizer unveiled a new logo featuring a double helix and updated font, replacing its previous oval logo. The company said the identity signals a shift from commerce to science.
2020
FDA authorizes Pfizer COVID-19 vaccine for emergency use
The U.S. Food and Drug Administration authorized the Pfizer COVID-19 vaccine for emergency use, making it the first COVID-19 vaccine authorized in the United States.
2020
Malaysia finalizes Pfizer vaccine supply agreement
Malaysia finalized an agreement to purchase 12.8 million doses of Pfizer's Covid-19 vaccine, with delivery scheduled to begin in the first quarter of 2021.
2020
Pfizer launches vaccine delivery pilot in four states
Pfizer launched a pilot program to test COVID-19 vaccine delivery processes in Rhode Island, Texas, New Mexico, and Tennessee. The states were not to receive vaccine doses earlier than other states because of the pilot.
2020
CStone completes approximately $200 million share subscription by Pfizer affiliate
CStone announced that a Pfizer affiliate completed a subscription for newly issued CStone shares worth approximately US$200 million, representing about 9.90% of CStone's enlarged issued share capital.
2020
True Office Learning wins Brandon Hall Gold award with Pfizer
True Office Learning announced that it received a Brandon Hall Gold award with Pfizer for Best Advance in Compliance Training, recognizing a compliance training program it built for Pfizer.